Assessment of the Effectiveness of Menopur in Intrauterine Insemination

March 27, 2025 updated by: Ferring Pharmaceuticals

Assessment of the Clinical Efficacy of Menopur® in Intrauterine Artificial Insemination (From Partner or From Donor)

The purpose of this study is to assess the effectiveness of Menopur to achieve clinical pregnancy in females undergoing intrauterine insemination in clinical practice.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

207

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Albacete, Spain
        • Investigational Site
      • Alicante, Spain
        • Investigational Site
      • Almería, Spain
        • Investigational Site
      • Barcelona, Spain
        • Investigational Site
      • Burgos, Spain
        • Investigational Site
      • León, Spain
        • Investigational Site
      • Madrid, Spain
        • Investigational Site
      • Sevilla, Spain
        • Investigational Site
      • Toldeo, Spain
        • Investigational Site
      • Valladolid, Spain
        • Investigational Site
    • Alicante
      • Elche, Alicante, Spain
        • Investigational Site
    • Grand Canaria
      • Las Palmas, Grand Canaria, Spain
        • Investigational Site
    • La Coruña
      • Santiago, La Coruña, Spain
        • Investigational Site
    • Tarragona
      • Reus, Tarragona, Spain
        • Investigational Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Females affected by infertility able to undergo intrauterine insemination

Description

Inclusion Criteria:

  • Infertile couples for over one year (primary or secondary) or infertile women (or not) with indication of PAI or DAI
  • Seminal sample suitable for artificial insemination treatment according to the criterion of each centre
  • Patient prescribed therapy with Menopur in artificial insemination

Exclusion Criteria:

  • Contraindications to intrauterine insemination
  • Contraindications to Menopur

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
hMG
Drug: hMG
Patients with a condition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Clinical pregnancy rate
Time Frame: 30 days
30 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Live birth rate
Time Frame: 40 weeks
40 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ferring Pharmaceuticals

Collaborators

Ferring SAU

Investigators

  • Study Director: Clinical Development Support, Ferring Pharmaceuticals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2004

Primary Completion (Actual)

December 1, 2005

Study Completion (Actual)

April 1, 2006

Study Registration Dates

First Submitted

May 16, 2011

First Submitted That Met QC Criteria

May 16, 2011

First Posted (Estimated)

May 17, 2011

Study Record Updates

Last Update Posted (Actual)

March 28, 2025

Last Update Submitted That Met QC Criteria

March 27, 2025

Last Verified

May 1, 2011

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FER-MEN-2003-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on hMG

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe